US Bancorp
TMCI icon

US Bancorp’s Treace Medical Concepts TMCI Stock Holding History

US Bancorp’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-657
Closed -$4.41K – 4198
2025
Q3 		$4.41K Buy
657
+244
+59% +$1.59K ﹤0.01% 3577
2025
Q2 		$2.43K Sell
413
-185
-31% -$1.21K ﹤0.01% 3830
2025
Q1 		$5.02K Buy
598
+20
+3% +$180 ﹤0.01% 3659
2024
Q4 		$4.3K Buy
578
+269
+87% +$1.8K ﹤0.01% 3684
2024
Q3 		$1.79K Sell
309
-371
-55% -$2.38K ﹤0.01% 3813
2024
Q2 		$4.52K Buy
680
+268
+65% +$2.17K ﹤0.01% 3553
2024
Q1 		$5.38K Buy
412
+59
+17% +$787 ﹤0.01% 3507
2023
Q4 		$4.5K Buy
353
+268
+315% +$2.71K ﹤0.01% 3559
2023
Q3 		$1.11K Buy
+85
New +$1.56K ﹤0.01% 3752
2023
Q2 		– Sell
-18
Closed -$453 – 4133
2023
Q1 		$453 Buy
+18
New +$423 ﹤0.01% 3963

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

US Bancorp's TMCI Position: Q4 2025 in Review

US Bancorp sold out of Treace Medical Concepts (TMCI) in Q4 2025, closing a stake of 657 shares — an estimated $4.41K sold.

US Bancorp first reported a position in TMCI in Q1 2023 and held it in 10 quarters. The position peaked at $5.38K in Q1 2024. 115 funds tracked by Wall St. Rank hold TMCI as of Q4 2025.

  • US Bancorp reported no remaining Treace Medical Concepts position as of Q4 2025 after selling out during the quarter.
  • US Bancorp sold 657 Treace Medical Concepts shares in Q4 2025, an estimated $4.41K.
  • US Bancorp first reported a position in Treace Medical Concepts in Q1 2023 and held it in 10 quarters.
  • US Bancorp's Treace Medical Concepts position peaked at $5.38K in Q1 2024.
  • 115 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q4 2025.

Based on US Bancorp's 13F filing for Q4 2025, filed 30 Jan 2026.